endofocusFOCUS ЭндокринологияFOCUS. Endocrinology2713-01772713-0185ООО "Издательство "Перо"10.15829/2713-0177-2023-4-29endofocus-48Research ArticleСтатьиБлагоприятный исход беременности у пациентки с акромегалией на фоне терапии аналогами соматостатина и каберголиномSuccessful pregnancy in a patient with acromegaly after somatostatin analogues and cabergoline treatment. therapy with somatostatin analogues and cabergolinehttps://orcid.org/0009-0004-3910-0321КнязеваО. В.KnyazevaO. V.

 к.м.н.

117036, Москва, улица Дм. Ульянова, д.11

Olga V. Knyazeva – Cand. Sci. (Med.)

11 Dm.Ulyanova street, 117036 Moscow

knyazeva.olga@endocrincentr.ruhttps://orcid.org/0000-0001-7470-1676ВоротниковаС. Ю.VorotnikovaS. Yu.

к.м.н.

117036, Москва, улица Дм. Ульянова, д.11

Svetlana Yu. Vorotnikova – Cand. Sci. (Med.)

11 Dm.Ulyanova street, 117036 Moscow

vorotnikova.svetlana@endocrincentr.ruhttps://orcid.org/0000-0001-6470-6318ВолеводзН. Н.VolevodzN. N.

д.м.н., зам. директора по клинико-диагностической работе

117036, Москва, улица Дм. Ульянова, д.11

Natal’ya N. Volevodz – Doctor of Science, deputy head of director

11 Dm.Ulyanova street, 117036 Moscow

nnvolevodz@mail.ruhttps://orcid.org/0000-0002-0327-4619ДзерановаЛ. К.DzeranovaL. K.

д.м.н., г.н.c.

117036, Москва, улица Дм. Ульянова, д.11

Larisa K. Dzeranova – D. Sci. (Med.)

11 Dm.Ulyanova street, 117036 Moscow

dzeranova.larisa@endocrincentr.ruФГБУ «Национальный медицинский исследовательский центр эндокринологии»Endocrinology Research Centre20231812202344Нейроэндокринология7074Copyright © Князева О.В., Воротникова С.Ю., Волеводз Н.Н., Дзеранова Л.К., 20242024Князева О.В., Воротникова С.Ю., Волеводз Н.Н., Дзеранова Л.К.Knyazeva O.V., Vorotnikova S.Y., Volevodz N.N., Dzeranova L.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://endofocus.elpub.ru/jour/article/view/48

Вероятность наступления беременности у женщин с акромегалией достаточно низкая, однако современные методы терапии позволяют достичь компенсации заболевания и восстановления репродуктивной функции.

Мировой опыт ведения беременности у пациенток с акромегалией в настоящее время не достаточен. Вынашивание беременности может быть ассоциировано с повышенным риском как для матери, так и плода в связи с возможным ростом опухоли, развитием метаболических осложнений (сахарный диабет, артериальная гипертензия).

В настоящей статье описан случай благополучного течения беременности у женщины с активной формой акромегалии, наступившей на фоне терапии аналогами соматостатина.

The probability of pregnancy in women with acromegaly is relatively low, however modern therapy approaches make it possible to achieve disease compensation and improve reproductive function.

World expert’s experience in managing pregnancy in patients with acromegaly is currently insufficient. Pregnancy may be associated with an increased risk for both mother and fetus due to the possible growth of the tumor, the development of metabolic complications (diabetes mellitus, arterial hypertension).

This article describes a case of a successful pregnancy in a woman with active acromegaly occurring after somatostatin analogues and cabergoline treatment.

АкромегалиябеременностьИРФ-1гормон ростааденома гипофизапролактинAcromegalypregnancyIGF-1growth hormonepituitary tumorprolactinReferencesPopescu AD, Carsote M, Valea A, Nicola AG, Dascălu IT, Tircă T, Abdul-Razzak J, Țuculină MJ. Approach of Acromegaly during Pregnancy. Diagnostics (Basel). 2022 Nov 2;12(11):2669. doi: 10.3390/diagnostics12112669.Popescu AD, Carsote M, Valea A, Nicola AG, Dascălu IT, Tircă T, Abdul-Razzak J, Țuculină MJ. Approach of Acromegaly during Pregnancy. Diagnostics (Basel). 2022 Nov 2;12(11):2669. doi: 10.3390/diagnostics12112669.Пронин А.В., Кирющенков А. П., Мельниченко Г. А., Хохлова И. Д., Федорова Е. В., Пронин В. С., Гитель Е. П. Репродуктивная система женщин с акромегалией. Вестник репродуктивного здоровья. 2011;1:32–39. doi: 10.14341/BRH2011132-39.Пронин А.В., Кирющенков А. П., Мельниченко Г. А., Хохлова И. Д., Федорова Е. В., Пронин В. С., Гитель Е. П. Репродуктивная система женщин с акромегалией. Вестник репродуктивного здоровья. 2011;1:32–39. doi: 10.14341/BRH2011132-39.Зайдиева Я.З., Рифатова А. В. Акромегалия у женщин: взгляд гинеколога. Российский вестник акушера-гинеколога. 2014; 14(3):38 42.Зайдиева Я.З., Рифатова А. В. Акромегалия у женщин: взгляд гинеколога. Российский вестник акушера-гинеколога. 2014; 14(3):38 42.Grynberg M, Salenave S, Young J, Chanson P. Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab. 2010 Oct;95(10):4518–25. doi: 10.1210/jc.2009-2815.Grynberg M, Salenave S, Young J, Chanson P. Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab. 2010 Oct;95(10):4518–25. doi: 10.1210/jc.2009-2815.McCartney, C. R., & Marshall, J. C. (2019). Neuroendocrinology of Reproduction. Yen and Jaffe’s Reproductive Endocrinology, 1–24.e8. doi:10.1016/b978-0-323-47912-7.00001-9.McCartney, C. R., & Marshall, J. C. (2019). Neuroendocrinology of Reproduction. Yen and Jaffe’s Reproductive Endocrinology, 1–24.e8. doi:10.1016/b978-0-323-47912-7.00001-9.Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 1988 Aug;50(2):197–212. doi: 10.1016/s0015-0282(16)60060-2. PMID: 3294042.Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 1988 Aug;50(2):197–212. doi: 10.1016/s0015-0282(16)60060-2. PMID: 3294042.Kaltsas GA, Mukherjee JJ, Jenkins PJ, et al. Menstrual irregularity in women with acromegaly. J Clin Endocrinol Metab. 1999; 84(8):2731–2735. doi:10.1210/jcem.84.8.5858.Kaltsas GA, Mukherjee JJ, Jenkins PJ, et al. Menstrual irregularity in women with acromegaly. J Clin Endocrinol Metab. 1999; 84(8):2731–2735. doi:10.1210/jcem.84.8.5858.Kupersmith MJ, Rosenberg C, Kleinberg D. Visual loss in pregnant women with pituitary adenomas. Ann Intern Med. 1994;121(7):473–477. doi:10.7326/0003-4819-121-7-199410010-00001.Kupersmith MJ, Rosenberg C, Kleinberg D. Visual loss in pregnant women with pituitary adenomas. Ann Intern Med. 1994;121(7):473–477. doi:10.7326/0003-4819-121-7-199410010-00001.Leung KC, Johannsson G, Leong GM, Ho KK. Estrogen regulation of growth hormone action. Endocr Rev. 2004;25(5):693–721. doi:10.1210/er.2003-0035.Leung KC, Johannsson G, Leong GM, Ho KK. Estrogen regulation of growth hormone action. Endocr Rev. 2004;25(5):693–721. doi:10.1210/er.2003-0035.Caron P, Broussaud S, Bertherat J, et al. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab. 2010;95(10):4680–4687. doi:10.1210/jc.2009-2331.Caron P, Broussaud S, Bertherat J, et al. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab. 2010;95(10):4680–4687. doi:10.1210/jc.2009-2331.Colao A, Merola B, Ferone D, Lombardi G. Acromegaly. J Clin Endocrinol Metab. 1997; 82(9):2777–2781. doi:10.1210/jcem.82.9.4257.Colao A, Merola B, Ferone D, Lombardi G. Acromegaly. J Clin Endocrinol Metab. 1997; 82(9):2777–2781. doi:10.1210/jcem.82.9.4257.Neal JM. Successful pregnancy in a woman with acromegaly treated with octreotide. Endocr Pract. 2000; 6(2):148–150. doi:10.4158/EP.6.2.148.Neal JM. Successful pregnancy in a woman with acromegaly treated with octreotide. Endocr Pract. 2000; 6(2):148–150. doi:10.4158/EP.6.2.148.Katznelson L, Laws ER Jr, Melmed S, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933–3951. doi:10.1210/jc.2014-2700.Katznelson L, Laws ER Jr, Melmed S, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933–3951. doi:10.1210/jc.2014-2700.Molitch ME. Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011; 25(6):885–896. doi:10.1016/j.beem.2011.05.011.Molitch ME. Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011; 25(6):885–896. doi:10.1016/j.beem.2011.05.011.Jallad RS, Shimon I, Fraenkel M, et al. Outcome of pregnancies in a large cohort of women with acromegaly. Clin Endocrinol (Oxf). 2018; 88(6):896–907. doi:10.1111/cen.13599.Jallad RS, Shimon I, Fraenkel M, et al. Outcome of pregnancies in a large cohort of women with acromegaly. Clin Endocrinol (Oxf). 2018; 88(6):896–907. doi:10.1111/cen.13599.Mikhail N. Octreotide treatment of acromegaly during pregnancy. Mayo Clin Proc. 2002;77(3):297–298. doi:10.4065/77.3.297-a.Mikhail N. Octreotide treatment of acromegaly during pregnancy. Mayo Clin Proc. 2002;77(3):297–298. doi:10.4065/77.3.297-a.Cheng S, Grasso L, Martinez-Orozco JA, et al. Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin Endocrinol (Oxf). 2012;76(2):264–271. doi:10.1111/j.1365-2265.2011.04180.x.Cheng S, Grasso L, Martinez-Orozco JA, et al. Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin Endocrinol (Oxf). 2012;76(2):264–271. doi:10.1111/j.1365-2265.2011.04180.x.Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab. 2007;92(9):3374–3377. doi:10.1210/jc.2007-0997.Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab. 2007;92(9):3374–3377. doi:10.1210/jc.2007-0997.Molitch ME. Pituitary tumors and pregnancy. Growth Horm IGF Res. 2003;13 Suppl A: S38-S44. doi:10.1016/s1096-6374(03)00054-6.Molitch ME. Pituitary tumors and pregnancy. Growth Horm IGF Res. 2003;13 Suppl A: S38-S44. doi:10.1016/s1096-6374(03)00054-6.Hannon AM, Frizelle I, Kaar G, et al. Octreotide use for rescue of vision in a pregnant patient with acromegaly [published online ahead of print, 2019 May 20]. Endocrinol Diabetes Metab Case Rep. 2019; 2019:19–0019. doi:10.1530/EDM-19-0019.Hannon AM, Frizelle I, Kaar G, et al. Octreotide use for rescue of vision in a pregnant patient with acromegaly [published online ahead of print, 2019 May 20]. Endocrinol Diabetes Metab Case Rep. 2019; 2019:19–0019. doi:10.1530/EDM-19-0019.Jallad RS, Shimon I, Fraenkel M, et al. Outcome of pregnancies in a large cohort of women with acromegaly. Clin Endocrinol (Oxf). 2018;88(6):896–907. doi:10.1111/cen.13599.Jallad RS, Shimon I, Fraenkel M, et al. Outcome of pregnancies in a large cohort of women with acromegaly. Clin Endocrinol (Oxf). 2018;88(6):896–907. doi:10.1111/cen.13599.Bandeira DB, Olivatti TOF, Bolfi F, Boguszewski CL, Dos Santos Nunes-Nogueira V. Acromegaly and pregnancy: a systematic review and meta-analysis. Pituitary. 2022; 25(3):352–362. doi:10.1007/s11102-022-01208-0.Bandeira DB, Olivatti TOF, Bolfi F, Boguszewski CL, Dos Santos Nunes-Nogueira V. Acromegaly and pregnancy: a systematic review and meta-analysis. Pituitary. 2022; 25(3):352–362. doi:10.1007/s11102-022-01208-0.Herman-Bonert V, Seliverstov M, Melmed S. Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab. 1998; 83(3):727–731. doi:10.1210/jcem.83.3.4635.Herman-Bonert V, Seliverstov M, Melmed S. Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab. 1998; 83(3):727–731. doi:10.1210/jcem.83.3.4635.

The authors declare that there are no conflicts of interest present.